4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-032505
CEO, CFO, Director gave up 1,792 shares (to pay taxes)
- CEO, CFO, Director acquired 5,558 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2023-09-11 | Option exercise | +5,558 | 15,186 | D | ||
| Finley John David CEO, CFO, Director | 2023-09-12 | Shares withheld for taxes | −1,792 | $0.66 | $1,174 | 13,394 | D |
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2023-09-11 | Option exercise · Restricted Stock Units | −5,558 | 61,142 | D | ||
Loading xslF345X05/ownership.xml…